Search Count: 27
 |
Crystal Structure Of Bptf-Brd With Ligand Dc-Bpi-07 Bound
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2022-06-29 Classification: ANTITUMOR PROTEIN Ligands: EUU |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-06-29
Ligands: EUU
 |
Crystal Structure Of Bptf-Brd With Ligand Dc-Bpi-03 Bound
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2022-06-29 Classification: ANTITUMOR PROTEIN Ligands: EUO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-06-29
Ligands: EUO
 |
Crystal Structure Of Bptf-Brd With Ligand Dc-Bpi-11 Bound
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2022-06-29 Classification: ANTITUMOR PROTEIN Ligands: 1IY |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-06-29
Ligands: 1IY
 |
Crystal Structure Of Bptf-Brd With Ligand Dcbpin5 Bound
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2021-04-28 Classification: ANTITUMOR PROTEIN Ligands: EUO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-04-28
Ligands: EUO
 |
Crystal Structure Of Bptf-Brd With Ligand Dcbpin5-2 Bound
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2021-04-28 Classification: ANTITUMOR PROTEIN Ligands: EUU |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-04-28
Ligands: EUU
 |
Crebbp Bromodomain In Complex With Cpd3 ((S)-1-(3-(6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: 9U7 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: 9U7
 |
Crebbp Bromodomain In Complex With Cpd8 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.43 Å Release Date: 2018-03-07 Classification: TRANSFERASE/INHIBITOR Ligands: 9UA, DMS, GOL |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: 9UA, DMS, GOL
 |
Crebbp Bromodomain In Complex With Cpd10 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydro-2H-Pyran-4-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: 9UD |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: 9UD
 |
Crebbp Bromodomain In Complex With Cpd17 (N,2,7-Trimethyl-2,3-Dihydro-4H-Benzo[B][1,4]Oxazine-4-Carboxamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: SO4, 9UG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: SO4, 9UG
 |
Crystal Structure Of The Bromodomain Of Human Crebbp Bound To Pyrazolopiperidine Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.38 Å Release Date: 2016-11-02 Classification: TRANSFERASE Ligands: 6XB, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-02
Ligands: 6XB, DMS
 |
Crebbp Bromodomain In Complex With Cpd 44 (3-((5-Acetyl-1-(Cyclopropylmethyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridin-3-Yl)Amino)-N-Isopropylbenzamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.09 Å Release Date: 2016-11-02 Classification: TRANSFERASE Ligands: 6XG, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-02
Ligands: 6XG, EDO
 |
Crebbp Bromodomain In Complex With Cpd59 ((S)-1-(3-((2-Fluoro-4-(1-Methyl-1H-Pyrazol-4-Yl)Phenyl)Amino)-1-(Tetrahydrofuran-3-Yl)-6,7-Dihydro-1H-Pyrazolo[4,3-C]Pyridin-5(4H)-Yl)Ethanone)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.27 Å Release Date: 2016-11-02 Classification: TRANSFERASE Ligands: 6XH, EDO, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-02
Ligands: 6XH, EDO, DMS
 |
Brd4 Bromodomain In Complex With Cpd59 ((S)-1-(3-((2-Fluoro-4-(1-Methyl-1H-Pyrazol-4-Yl)Phenyl)Amino)-1-(Tetrahydrofuran-3-Yl)-6,7-Dihydro-1H-Pyrazolo[4,3-C]Pyridin-5(4H)-Yl)Ethanone)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.14 Å Release Date: 2016-11-02 Classification: TRANSFERASE Ligands: EDO, DMS, GOL, PEG, 6XH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-02
Ligands: EDO, DMS, GOL, PEG, 6XH
 |
Discovery Of An Irreversible Hcv Ns5B Polymerase Inhibitor
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2013-12-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2F3, PO4 |
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION
Release Date: 2013-12-11
Ligands: 2F3, PO4
 |
Hcv Ns5B Polymerase Complexed With Pyridonylindole Compound
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2013-10-09 Classification: TRANSFERASE Ligands: 8Y6, PO4 |
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION
Release Date: 2013-10-09
Ligands: 8Y6, PO4
 |
Sar Development And Discovery Of Potent Indole-Based Inhibitors Of The Hepatitis C Virus Ns5B Polymerase
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2012-02-01 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: HI4, PO4 |
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION
Release Date: 2012-02-01
Ligands: HI4, PO4
 |
Sar Development And Discovery Of Potent Indole-Based Inhibitors Of The Hepatitis C Virus Ns5B Polymerase
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2012-02-01 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: PO4, HI3 |
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION
Release Date: 2012-02-01
Ligands: PO4, HI3
 |
Novel Hcv Ns5B Polymerase Inhibitors: Discovery Of Indole C2 Acyl Sulfonamides
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2011-12-07 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 08E, PO4 |
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: 08E, PO4
 |
Novel Hcv Ns5B Polymerase Inhibitors: Discovery Of Indole C2 Acyl Sulfonamides
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2011-12-07 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 08F |
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: 08F
 |
I. Novel Hcv Ns5B Polymerase Inhibitors: Discovery Of Indole 2- Carboxylic Acids With C3-Heterocycles
Organism: Hepatitis c virus isolate hc-j4
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2011-08-31 Classification: transferase/transferase INHIBITOR Ligands: PO4, 053 |
Organism: Hepatitis c virus isolate hc-j4
Method: X-RAY DIFFRACTION
Release Date: 2011-08-31
Ligands: PO4, 053